AU2022419178A1 - Methods and compositions for improving exercise performance - Google Patents
Methods and compositions for improving exercise performance Download PDFInfo
- Publication number
- AU2022419178A1 AU2022419178A1 AU2022419178A AU2022419178A AU2022419178A1 AU 2022419178 A1 AU2022419178 A1 AU 2022419178A1 AU 2022419178 A AU2022419178 A AU 2022419178A AU 2022419178 A AU2022419178 A AU 2022419178A AU 2022419178 A1 AU2022419178 A1 AU 2022419178A1
- Authority
- AU
- Australia
- Prior art keywords
- fontan
- udenafil
- patient
- pharmaceutically acceptable
- exercise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291858P | 2021-12-20 | 2021-12-20 | |
| US63/291,858 | 2021-12-20 | ||
| PCT/US2022/000033 WO2023121689A1 (en) | 2021-12-20 | 2022-12-20 | Methods and compositions for improving exercise performance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022419178A1 true AU2022419178A1 (en) | 2024-08-08 |
Family
ID=85382567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022419178A Pending AU2022419178A1 (en) | 2021-12-20 | 2022-12-20 | Methods and compositions for improving exercise performance |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240285630A1 (https=) |
| EP (1) | EP4452273A1 (https=) |
| JP (1) | JP2025504706A (https=) |
| CN (1) | CN119072312A (https=) |
| AU (1) | AU2022419178A1 (https=) |
| CA (1) | CA3243958A1 (https=) |
| MX (1) | MX2024007796A (https=) |
| WO (1) | WO2023121689A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TN2017000029A1 (en) | 2014-08-12 | 2018-07-04 | Mezzion Pharma Co Ltd | Methods of improving myocardial performance in fontan patients using udenafil compositions |
| AU2020356193A1 (en) * | 2019-09-24 | 2022-05-19 | Children's Hospital Of Philadelphia | Methods of improving exercise performance, single ventricular performance, and myocardial performance index (MPI) in single ventricle heart disease, using udenafil compositions |
-
2022
- 2022-12-20 CN CN202280092060.3A patent/CN119072312A/zh active Pending
- 2022-12-20 US US17/803,841 patent/US20240285630A1/en active Pending
- 2022-12-20 JP JP2024537409A patent/JP2025504706A/ja active Pending
- 2022-12-20 EP EP22862347.6A patent/EP4452273A1/en active Pending
- 2022-12-20 AU AU2022419178A patent/AU2022419178A1/en active Pending
- 2022-12-20 WO PCT/US2022/000033 patent/WO2023121689A1/en not_active Ceased
- 2022-12-20 CA CA3243958A patent/CA3243958A1/en active Pending
-
2024
- 2024-06-20 MX MX2024007796A patent/MX2024007796A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024007796A (es) | 2025-04-02 |
| CA3243958A1 (en) | 2023-06-29 |
| EP4452273A1 (en) | 2024-10-30 |
| US20240285630A1 (en) | 2024-08-29 |
| JP2025504706A (ja) | 2025-02-17 |
| CN119072312A (zh) | 2024-12-03 |
| WO2023121689A1 (en) | 2023-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guazzi et al. | Long-term use of sildenafil in the therapeutic management of heart failure | |
| US20250186448A1 (en) | Formulations of udenafil | |
| JP2024020187A (ja) | ウデナフィル組成物を用いてフォンタン患者における心筋性能を改善する方法 | |
| JP2025118624A (ja) | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ｍｐｉ）を改善する方法 | |
| US20240285630A1 (en) | Methods and compositions for improving exercise performance |